Abingdon Health PLC
LSE:ABDX

Watchlist Manager
Abingdon Health PLC Logo
Abingdon Health PLC
LSE:ABDX
Watchlist
Price: 8.225 GBX 2.81% Market Closed
Market Cap: 15.9m GBX
Have any thoughts about
Abingdon Health PLC?
Write Note

Abingdon Health PLC
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abingdon Health PLC
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Abingdon Health PLC
LSE:ABDX
Short-Term Debt
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ConvaTec Group PLC
LSE:CTEC
Short-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Tristel PLC
LSE:TSTL
Short-Term Debt
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inspecs Group PLC
LSE:SPEC
Short-Term Debt
ÂŁ887k
CAGR 3-Years
-30%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Advanced Medical Solutions Group PLC
LSE:AMS
Short-Term Debt
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Rua Life Sciences PLC
LSE:RUA
Short-Term Debt
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Abingdon Health PLC
Glance View

Market Cap
15.9m GBX
Industry
Health Care

Abingdon Health Plc develops, manufactures and commercializes immunoassay tests and reader systems. The company is headquartered in York, North Yorkshire and currently employs 151 full-time employees. The company went IPO on 2020-12-15. The firm operates through three segments: Contract Development, Contract Manufacturing and Product Sales. The Contract Development segment comprises development work for third parties and is recognized over time based on a proportion of completion. The Contract Manufacturing segment comprises contract development and manufacturing activities. The Product Sales segment comprises the sale of ABC-19, pocket diagnostic products, progressive rod cone degeneration (PCRD) tests and antibodies for research use. Its products also include Seralite, which includes Free Light Chain (FLC) Serum. The Company’s geographical market include the United Kingdom, the United States/Canada, rest of world (ROW).

ABDX Intrinsic Value
11.84 GBX
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Abingdon Health PLC's Short-Term Debt?
Short-Term Debt
0 GBP

Based on the financial report for Jun 30, 2023, Abingdon Health PLC's Short-Term Debt amounts to 0 GBP.

Back to Top